findmyKOL

Anekwe Onwuanyi, MD

Basic profile

Morehouse School of Medicine

ORCIDNPI
RegionAtlanta, GA · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH funding2005–2011

Anekwe Onwuanyi is a Cardiology physician affiliated with Morehouse School of Medicine. OpenAlex indexes 110 publications with 851 citations (h-index 15).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
110publications

Distinct works indexed by OpenAlex, matched via ORCID.

851citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2005–2011

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

80 Jessie Hill Jr Drive
Ste 2e
Atlanta, GA 30303

Telephone

404-616-4422

Provider last certified this registry record 31 Jul 2020.

View the NPPES registry record

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.8%
    Beta blocker18.3%
    Metoprolol Succinate58%Carvedilol42%
    Part D56 patients
    Statin13.4%
    Atorvastatin Calcium63%Rosuvastatin Calcium26%Pravastatin Sodium11%
    Part D<11 patients

    + 11 more classes in this area

  • Metabolism & gastrointestinal

    7.7%
    SGLT2 inhibitor7.7%
    Farxiga77%Jardiance23%
    Part D<11 patients
  • Blood & clotting

    6.1%
    Factor Xa inhibitor6.1%
    Eliquis71%Xarelto29%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20052011 per NIH RePORTER. The latest:

6 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”